TY  - GEN
AU  - Bolland,Mark J
AU  - Grey,Andrew B
AU  - Horne,Anne M
AU  - Briggs,Simon E
AU  - Thomas,Mark G
AU  - Ellis-Pegler,Rod B
AU  - Callon,Karen E
AU  - Gamble,Greg D
AU  - Reid,Ian R
TI  - Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months
SN  - 1523-4681
PY  - 2008///1006
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Bone and Bones
KW  - Diphosphonates
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - HIV Infections
KW  - physiopathology
KW  - Humans
KW  - Imidazoles
KW  - Injections, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Placebos
KW  - Time Factors
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1359/jbmr.080312
ER  -